866-997-4948(US-Canada Toll Free)

Radiodermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Published By :


Published Date : Jan 2024

Category :


No. of Pages : N/A

Radiodermatitis alternatively known as radiation dermatitis is a significant symptom caused by radiation therapy for the treatment of cancerous as well as non-cancerous disease or conditions. Cumulative daily doses of radiation to the treatment field or target site on the body prevents normal skin to repopulate and weakens the skin integrity at and around the radiation field. Radiodermatitis may be acute or chronic and encompasses localized erythema, skin shedding (desquamation), hair loss (epilation), fibrosis, necrosis and other similar conditions. The side effects of the Radiodermatitis affect the patient’s quality of life, cause pain and discomfort and hinders in the continuous treatment regimes. Radiodermatitis also may cause interruption in or cessation of treatment, depending on the severity of reaction.

In developed economic countries such as Europe, Canada, United States and Australia, approximately 60% of the patients diagnosed with cancer undergo chemotherapy of which 95% of the population may receive some degree of skin reaction such as erythema, dry desquamation, and moist desquamation among others. Major factors responsible for radiodermatitis is either treatment related or patient related. Treatment related risk factors encompasses type & quality of beam, doses amount, location and size of the treatment field. Modern radiotherapy techniques such as intensity-modulated radiation therapy (IMRT) and proton therapy in past few years have minimized the risk for radiodermatitis by precisely targeting the tumor cell thus sparing normal cells and tissues. Patient related factors include obesity, extremely poor nutritional status, smoking, individual radio sensitivity and other diseases such as autoimmune diseases. 

Most of the dugs/vaccines are in the clinical trial phases and many of them are awaited for FDA approval. Most physicians and oncologists prefer off-label drugs such as Carac top, Fluoroplex top, Efudex top, fluorouracil top and others on a case to case basis. The drivers for the market include increasing cancer patient population opting for chemotherapy or radiation therapy. In 2012 according to WHO cancer patient accounted for 8.2 million worldwide. As per Cancer Treatment & Survivorship Facts by 2022 it is estimated that number of cancer survivor is estimated to increase and will reach up to 18 million in the U.S. which as of 2012 is approximately 13.7 million. Some of companies and universities working on pipeline vaccines against radiodermatitis comprises ProCertus BioPharm Inc., Stemnion, Inc., Futurum Group Pty Ltd, APEIRON Biologics AGand University of Rochester among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports